| dbo:abstract
|
- Triflupromazin, ein Phenothiazin-Derivat, wurde als Neuroleptikum und Antiemetikum verwendet. Aufgrund veränderter Zulassungsvoraussetzungen ist es seit 2003 in Deutschland nicht mehr im Handel (ehemaliger Handelsname: Psyquil®). (de)
- La triflupromazine est une phénothiazine utilisée comme antipsychotique et antiémétique. (fr)
- Triflupromazine (Vesprin) is an antipsychotic medication of the phenothiazine class. Among different effects of triflupromazine indication for use of this drug is severe emesis and severe Hiccups. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy. Serious side effects of triflupromazine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, neuroleptic malignant syndrome. (en)
- Triflupromazine is een klassiek antipsychoticum uit de fenothiazine groep dat in Nederland op de markt werd gebracht onder de naam Siquil. Triflupromazine veroorzaakt soms ernstige extrapiramidale bijwerkingen. Daarom is dit oude antipsychoticum van de markt gehaald. Tot de ernstige bijwerkingen die regelmatig optraden behoorden acathisie en tardieve dyskinesie en in enkele gevallen het potentieel dodelijke, maligne neuroleptisch syndroom. (nl)
|
| dbo:casNumber
| |
| dbo:chEBI
| |
| dbo:chEMBL
| |
| dbo:drugbank
| |
| dbo:fdaUniiCode
| |
| dbo:kegg
| |
| dbo:medlinePlus
| |
| dbo:pubchem
| |
| dbo:thumbnail
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 3110 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:atcPrefix
| |
| dbp:atcSuffix
| |
| dbp:c
| |
| dbp:casNumber
| |
| dbp:chebi
| |
| dbp:chembl
| |
| dbp:chemspiderid
| |
| dbp:drugbank
| |
| dbp:f
| |
| dbp:h
| |
| dbp:image
|
- Triflupromazine3d.png (en)
|
| dbp:iupacName
|
- N,N-dimethyl-3-[2--10H-phenothiazin-10-yl]propan-1-amine (en)
|
| dbp:iupharLigand
| |
| dbp:kegg
| |
| dbp:legalUs
| |
| dbp:medlineplus
| |
| dbp:n
| |
| dbp:pubchem
| |
| dbp:s
| |
| dbp:smiles
|
- CNCCCN1c2ccccc2Sc2cccCF (en)
|
| dbp:stdinchi
| |
| dbp:stdinchikey
|
- XSCGXQMFQXDFCW-UHFFFAOYSA-N (en)
|
| dbp:title
| |
| dbp:titlestyle
| |
| dbp:unii
| |
| dbp:verifiedfields
| |
| dbp:verifiedrevid
| |
| dbp:watchedfields
| |
| dbp:width
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Triflupromazin, ein Phenothiazin-Derivat, wurde als Neuroleptikum und Antiemetikum verwendet. Aufgrund veränderter Zulassungsvoraussetzungen ist es seit 2003 in Deutschland nicht mehr im Handel (ehemaliger Handelsname: Psyquil®). (de)
- La triflupromazine est une phénothiazine utilisée comme antipsychotique et antiémétique. (fr)
- Triflupromazine (Vesprin) is an antipsychotic medication of the phenothiazine class. Among different effects of triflupromazine indication for use of this drug is severe emesis and severe Hiccups. Due to its potential side effects (triflupromazine has higher risk for side effects than many other antipsychotics) it is not gold standard in antiemetic therapy. Serious side effects of triflupromazine can be akathisia and tardive dyskinesia as well as the rare, but potentially fatal, neuroleptic malignant syndrome. (en)
- Triflupromazine is een klassiek antipsychoticum uit de fenothiazine groep dat in Nederland op de markt werd gebracht onder de naam Siquil. Triflupromazine veroorzaakt soms ernstige extrapiramidale bijwerkingen. Daarom is dit oude antipsychoticum van de markt gehaald. Tot de ernstige bijwerkingen die regelmatig optraden behoorden acathisie en tardieve dyskinesie en in enkele gevallen het potentieel dodelijke, maligne neuroleptisch syndroom. (nl)
|
| rdfs:label
|
- Triflupromazin (de)
- Triflupromazine (fr)
- Triflupromazine (nl)
- Triflupromazine (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
